Sterile Injectable CDMO in India: Manufacturing, Fill-Finish, Technology & Regulatory Guide 2026

HEPA Filtration and HVAC

HVAC systems, including air-handling units, maintain the required air quality, temperature, humidity, and pressure differentials across classified areas. HEPA filtration removes airborne particles and is integral to achieving Grade A and B conditions.

Unidirectional airflow in Grade A zones relies on properly functioning terminal HEPA filters. Facilities must verify HEPA integrity and ensure that pressure cascades protect higher-grade areas from lower-grade zones. When selecting a CDMO, companies should review HVAC design, filter integrity testing records and differential-pressure monitoring data.

Environmental Monitoring

Environmental monitoring provides continuous verification that cleanrooms remain within specified limits. A robust program covers both viable and non-viable parameters.

Core elements include:

• Non-viable particle monitoring (continuous electronic tracking of particles ≥0.5 µm and ≥5.0 µm)
• Viable microbiological monitoring through active air sampling, settle plates, and surface or personnel contact plates/swabs
• Continuous tracking of temperature, relative humidity, and differential pressures
• HEPA integrity testing
• Predefined alert and action limits that trigger investigation or CAPA when exceeded

Data must be trended and reviewed under quality risk management principles. CDMOs that maintain comprehensive, real-time environmental monitoring programs offer stronger sterility assurance and regulatory readiness.

Media Fills / Aseptic Process Simulation

Media fills, also called aseptic process simulations, challenge the entire aseptic process with a sterile growth medium in place of the product. The simulation evaluates whether the process can consistently prevent microbial contamination under routine and worst-case conditions.

Successful media fills, performed at defined frequencies and with appropriate interventions, provide critical evidence of process capability. Buyers should confirm that a CDMO conducts media fills in accordance with Schedule M and current regulatory expectations and that the results support ongoing aseptic operations.

Sterility Assurance

Sterility assurance rests on an integrated Contamination Control Strategy that addresses every potential source of contamination. Essential components include:

• Personnel controls (gowning, qualification and limited intervention in Grade A/B areas)
• Controlled material transfer through airlocks
• Validated cleaning and disinfection programs
• Appropriate sterilization methods for equipment, components and product (where terminal sterilization is feasible)
• Container-closure integrity testing to confirm that the final sealed unit maintains sterility

Together, these measures reduce the risk of microbiological, particulate and pyrogen contamination. When assessing a sterile injectable CDMO in India, pharmaceutical companies should examine the facility’s Contamination Control Strategy, environmental monitoring data, media-fill history, HVAC performance and personnel training records.

Compliance with Revised Schedule M requirements in these areas provides a practical indicator of the CDMO’s ability to manufacture sterile products reliably and to meet both domestic and international regulatory standards.

Also Read: Pharma CDMOs in India & CDMO 2.0 Model: Detailed Review 2026